Exchange: NYSE·Updated 12:45 PM EDT
News
all
press releases
TFX vs. PEN: Which Stock Is the Better Value Option?
TFX vs. PEN: Which Stock Is the Better Value Option?
Zacks
More News
Is ANGO a Buy as Med Tech Growth Battles Persistent Margin Pressure?
AngioDynamics' Med Tech growth and reimbursement gains strengthen its outlook, but tariffs, rising costs and execution risks keep the buy case uncertain.
Zacks
Penumbra, Inc. Reports Second Quarter 2026 Financial Results
Penumbra, Inc. Reports Second Quarter 2026 Financial Results Penumbra, Inc. Reports Second Quarter 2026 Financial Results PR Newswire ALAMEDA, Calif., July 30, 2026 ALAMEDA, Calif., July 30, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leadingthrombectomy company, today reported...
PR Newswire
THUNDER Study Demonstrates Penumbra's THUNDERBOLT is Safe and Effective for Stroke Care
THUNDER Study Demonstrates Penumbra's THUNDERBOLT is Safe and Effective for Stroke Care THUNDER Study Demonstrates Penumbra's THUNDERBOLT is Safe and Effective for Stroke Care PR Newswire ALAMEDA, Calif., July 22, 2026 First and only CAVT device for stroke demonstrated high revascularization rates...
PR Newswire
IQV vs. PEN: Which Stock Is the Better Value Option?
IQV vs. PEN: Which Stock Is the Better Value Option?
Zacks
First Patient Enrolled in Penumbra's FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke
First Patient Enrolled in Penumbra's FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke First Patient Enrolled in Penumbra's FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal...
PR Newswire
GMED vs. PEN: Which Stock Should Value Investors Buy Now?
GMED vs. PEN: Which Stock Is the Better Value Option?
Zacks
Penumbra Receives CE Nod for THUNDERBOLT: Stock to Gain?
PEN gains CE Mark in Europe for THUNDERBOLT, expanding stroke treatment access and advancing its global stroke care strategy.
Zacks
ClearPoint Neuro (CLPT) Surges 26.0%: Is This an Indication of Further Gains?
ClearPoint Neuro (CLPT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks
Penumbra Expands CAVT for Stroke to Europe with CE Mark for THUNDERBOLT
Penumbra Expands CAVT for Stroke to Europe with CE Mark for THUNDERBOLT Penumbra Expands CAVT for Stroke to Europe with CE Mark for THUNDERBOLT PR Newswire ALAMEDA, Calif., June 15, 2026 The THUNDERBOLT TM Computer Assisted Vacuum Thrombectomy (CAVTTM) technology introduces modulated aspiration for...
PR Newswire

Advertisement|Remove ads.